AU5118493A - Aromatase inhibitor - Google Patents

Aromatase inhibitor

Info

Publication number
AU5118493A
AU5118493A AU51184/93A AU5118493A AU5118493A AU 5118493 A AU5118493 A AU 5118493A AU 51184/93 A AU51184/93 A AU 51184/93A AU 5118493 A AU5118493 A AU 5118493A AU 5118493 A AU5118493 A AU 5118493A
Authority
AU
Australia
Prior art keywords
aromatase inhibitor
aromatase
inhibitor
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU51184/93A
Inventor
Rolf W. Hartmann
Gerald Anton Wachter
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Tokyo Tanabe Co Ltd
Original Assignee
Tokyo Tanabe Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Tokyo Tanabe Co Ltd filed Critical Tokyo Tanabe Co Ltd
Publication of AU5118493A publication Critical patent/AU5118493A/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/56—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/64—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms, e.g. histidine

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AU51184/93A 1992-10-06 1993-10-06 Aromatase inhibitor Abandoned AU5118493A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP4-267130 1992-10-06
JP26713092 1992-10-06
PCT/JP1993/001433 WO1994007866A1 (en) 1992-10-06 1993-10-06 Aromatase inhibitor

Publications (1)

Publication Number Publication Date
AU5118493A true AU5118493A (en) 1994-04-26

Family

ID=17440495

Family Applications (1)

Application Number Title Priority Date Filing Date
AU51184/93A Abandoned AU5118493A (en) 1992-10-06 1993-10-06 Aromatase inhibitor

Country Status (2)

Country Link
AU (1) AU5118493A (en)
WO (1) WO1994007866A1 (en)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6329369B1 (en) 1997-12-04 2001-12-11 Allergan Sales, Inc. Methods of treating pain and other conditions
US6841684B2 (en) 1997-12-04 2005-01-11 Allergan, Inc. Imidiazoles having reduced side effects
ATE266643T1 (en) * 1997-12-04 2004-05-15 Allergan Inc SUBSTITUTED IMIDAZOLE DERIVATIVES WITH AN AGONIST-LIKE EFFECT ON THE ALPHA 2B OR 2B/2C ADRENERGIC RECEPTORS
AU2002254265B2 (en) * 1997-12-04 2008-05-15 Allergan, Inc. Imidiazole derivatives and their use as agonists selective at alpha 2B or 2B/2C adrenergic receptors
FR2787451B1 (en) * 1998-12-18 2001-01-26 Adir NOVEL IMIDAZOLINIC COMPOUNDS, PROCESS FOR THEIR PREPARATION AND THE PHARMACEUTICAL COMPOSITIONS CONTAINING THEM

Also Published As

Publication number Publication date
WO1994007866A1 (en) 1994-04-14

Similar Documents

Publication Publication Date Title
AU4251993A (en) Substituted 4-aza-5A-androstan-ones as 5A-reductase inhibitors
AU5533094A (en) Enzyme inhibitors
AU4166393A (en) Auto-reclosers
AU3561193A (en) TNF-muteins
AU3991693A (en) Pyrazinoindoles
AU3042892A (en) Rockbolt
AU7150991A (en) Aromatase inhibitors
AU4177593A (en) Benzophenonehydrazones
AU685767B2 (en) Substituted benzazepinones
AU667580B2 (en) Line-handling block
AU4156393A (en) Heterocyclyltriazolinones
AU664253B2 (en) Photo-deviometer
AU3562193A (en) Morpholin- and thiomorpholin-4-ylamides
AU3461693A (en) Saddle-cloth
AU4164793A (en) Heterocyclyltriazolinones
AU5118493A (en) Aromatase inhibitor
AU4632493A (en) Weathershed
AU2812195A (en) Inhibitor
AU5285593A (en) Azole compound
AU4864693A (en) Alkoxymethyl-substituted pyridonebiphenyls
AU3185693A (en) Pyrrolylbenzodiazepinones
AU8159594A (en) Novel inhibitor
ZA939480B (en) Enzyme inhibitor
AU5156793A (en) Eosinophil infiltration inhibitor
AU4354593A (en) Termite-proofing agent